My research interests focus on understanding immunosuppressive mechanisms in the tumor microenvironment. In particular, I have been studying indoleamine 2, 3-dioxygenase (IDO) and its inhibitory role on antitumor therapies targeting immune checkpoints, as well as the development of combinatorial therapeutic strategies using IDO inhibitors